News Headlines Article

California should update policy on biosimilar medicines
Sacramento Bee

A bill now on the governor’s desk – Senate Bill 598, which I authored – not only will save lives of patients with serious illnesses such as cancer, heart disease and Alzheimer’s disease, but also will grow California’s economy by expanding access to a new class of more affordable medicines called biosimilars.

The legislation is timely since these new treatments are expected to hit the U.S. health care market soon.